thioctic acid has been researched along with cadmium telluride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, AO; Jain, MP; Maysinger, D; Neibert, KD | 1 |
| Ling, Y; Meng, G; Yang, Y; Zhang, S; Zhang, W; Zhu, H | 1 |
2 other study(ies) available for thioctic acid and cadmium telluride
| Article | Year |
|---|---|
Probing and preventing quantum dot-induced cytotoxicity with multimodal alpha-lipoic acid in multiple dimensions of the peripheral nervous system.
Topics: Animals; Antioxidants; Cadmium Compounds; Cell Survival; Cells, Cultured; Cytoprotection; Ganglia, Spinal; Glutathione; Mice; PC12 Cells; Quantum Dots; Rats; Tellurium; Thioctic Acid | 2009 |
pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery.
Topics: Animals; Cadmium Compounds; Cell Hypoxia; Cell Survival; Deoxyglucose; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Glucose Transporter Type 1; Hep G2 Cells; Humans; Hydrazones; Hydrogen-Ion Concentration; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Lysine; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Oxygen; Peptides; Polyethylene Glycols; Quantum Dots; RNA, Small Interfering; RNAi Therapeutics; Tellurium; Thioctic Acid; Time Factors; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |